b.nakamura
Submits third-party assay reports on material purchased directly. Based in Haarlem.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
99.21%
n=7
Suppliers covered
6
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042572 | L-Glutathione (reduced) | HJ | HJ-2511-F6153 | PeptideMeter | 2026-Q2 | 99.93 | 7.33 | 98.3 | Buyer-sourced | 0 | PASS |
| AX-2026-042321 | Kisspeptin-10 | TFC | TFC-2604-B2419 | Janoshik | 2026-Q2 | 99.51 | 4.63 | 90.1 | Buyer-sourced | 0 | PASS |
| AX-2026-042747 | Semaglutide | GGPeps | GGPE-2603-W1490 | VendorInvestigate | 2026-Q2 | 99.21 | 3.35 | 102.6 | Buyer-sourced | 0 | PASS |
| AX-2026-042803 | Retatrutide | GGPeps | GGPE-2512-D2133 | Janoshik | 2026-Q2 | 98.51 | 3.75 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041568 | Semaglutide | QSC | QSC-2602-G7336 | Janoshik | 2026-Q1 | 98.68 | 5.03 | 91.3 | Laboratory-retained | 0 | PASS |
| AX-2025-020196 | TB-500 | ERP | ERP-2509-K9340 | Nordanalyt | 2025-Q4 | 99.38 | 2.19 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005091 | Glucagon | SSA | SSA-2408-F7321 | Janoshik | 2024-Q3 | 98.53 | 7.60 | 98.6 | Buyer-sourced | 0 | PASS |